心血管指南

订阅

MedSci主页 / 所有栏目 / 心血管指南

2021 ESC意见书：钠-葡萄糖共转体2抑制剂对于心脏、肾脏和代谢的影响

2021-08-23 欧洲心脏病学会 Eur J Heart Fail

钠-葡萄糖共转体2抑制剂

2021年8月，欧洲心脏病学会(ESC)钠-葡萄糖共转体2抑制剂小组发布了钠-葡萄糖共转体2抑制剂对于心脏、肾脏和代谢的影响的意见书。

中文标题：

2021 ESC意见书：钠-葡萄糖共转体2抑制剂对于心脏、肾脏和代谢的影响

英文标题：

Cardiac, renal, and metabolic effects of sodium-glucose co-transporter 2 inhibitors: a position paper from the European Society of Cardiology ad-hoc task force on sodium-glucose co-transporter 2 inhibitors

发布机构：

欧洲心脏病学会

发布日期：

2021-08-23

简要介绍：

2021年8月，欧洲心脏病学会(ESC)钠-葡萄糖共转体2抑制剂小组发布了钠-葡萄糖共转体2抑制剂对于心脏、肾脏和代谢的影响的意见书。本文总结了2021年初的10项大型研究的报告解雇，考虑了钠-葡萄糖共转体2(SGLT2)抑制剂的不同类型的心肾获益。

相关资料下载：
[AttachmentFileName(sort=1, fileName=2021 ESC意见书：钠-葡萄糖共转体2抑制剂对于心脏、肾脏和代谢的影响.pdf)] GetToolGuiderByIdResponse(projectId=1, id=7be241c00221a95b, title=2021 ESC意见书：钠-葡萄糖共转体2抑制剂对于心脏、肾脏和代谢的影响, enTitle=Cardiac, renal, and metabolic effects of sodium-glucose co-transporter 2 inhibitors: a position paper from the European Society of Cardiology ad-hoc task force on sodium-glucose co-transporter 2 inhibitors, guiderFrom=Eur J Heart Fail, authorId=0, author=, summary=2021年8月，欧洲心脏病学会(ESC)钠-葡萄糖共转体2抑制剂小组发布了钠-葡萄糖共转体2抑制剂对于心脏、肾脏和代谢的影响的意见书。, cover=https://img.medsci.cn/20211019/1634652483735_5579292.jpg, journalId=0, articlesId=null, associationId=62, associationName=欧洲心脏病学会, associationIntro=是目前在欧洲居于首要地位的心脏病学会，会员超过70000人、提供更新指南、调查数据、组织学术会议，ESC年会是心血管领域最大的会议。下设5个分会（超声心动图学会、心律学会、心衰学会、预防与康复学会及介入学会）。提供指南较全面，按年份排列。现提供有手机板本。, copyright=0, guiderPublishedTime=Mon Aug 23 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span style="color: #373737;">2021年8月，欧洲心脏病学会(ESC)钠-葡萄糖共转体2抑制剂小组发布了钠-葡萄糖共转体2抑制剂对于心脏、肾脏和代谢的影响的意见书。本文总结了2021年初的10项大型研究的报告解雇，考虑了钠-葡萄糖共转体2(SGLT2)抑制剂的不同类型的心肾获益。</span></p>, tagList=[TagDto(tagId=116211, tagName=钠-葡萄糖共转体2抑制剂)], categoryList=[CategoryDto(categoryId=2, categoryName=心血管, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=78559, guiderKeyword=钠-葡萄糖共转运蛋白-2抑制剂, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=2, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=2336, appHits=69, showAppHits=0, pcHits=1133, showPcHits=2267, likes=1, shares=5, comments=4, approvalStatus=1, publishedTime=Tue Oct 19 22:29:05 CST 2021, publishedTimeString=2021-08-23, pcVisible=1, appVisible=1, editorId=5579292, editor=FUNNYMAN, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=FUNNYMAN, createdTime=Tue Oct 19 22:10:46 CST 2021, updatedBy=5579292, updatedName=FUNNYMAN, updatedTime=Sat Jan 06 16:59:02 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021 ESC意见书：钠-葡萄糖共转体2抑制剂对于心脏、肾脏和代谢的影响.pdf)])
2021 ESC意见书：钠-葡萄糖共转体2抑制剂对于心脏、肾脏和代谢的影响.pdf
下载请点击：
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1073589, encodeId=9cef10e358979, content=有中文版的嘛, beContent=null, objectType=guider, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=31df6143751, createdName=ms6000001208327273, createdTime=Wed Nov 24 18:56:10 CST 2021, time=2021-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062246, encodeId=3167106224629, content=心衰四连, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07285599168, createdName=小蚂蚁uu, createdTime=Wed Oct 20 12:14:03 CST 2021, time=2021-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062161, encodeId=7cae106216112, content=！！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7d3a4700555, createdName=595690844, createdTime=Wed Oct 20 07:28:43 CST 2021, time=2021-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062109, encodeId=cc221062109ad, content=关注医学, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210313/9df56058b3964a8cac82563f95f0389d/c1b478592e8e4463bef44d32712e98fd.jpg, createdBy=ea905324251, createdName=SR~young海东, createdTime=Tue Oct 19 22:51:30 CST 2021, time=2021-10-19, status=1, ipAttribution=)]
    2021-11-24 ms6000001208327273

    有中文版的嘛

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1073589, encodeId=9cef10e358979, content=有中文版的嘛, beContent=null, objectType=guider, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=31df6143751, createdName=ms6000001208327273, createdTime=Wed Nov 24 18:56:10 CST 2021, time=2021-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062246, encodeId=3167106224629, content=心衰四连, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07285599168, createdName=小蚂蚁uu, createdTime=Wed Oct 20 12:14:03 CST 2021, time=2021-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062161, encodeId=7cae106216112, content=！！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7d3a4700555, createdName=595690844, createdTime=Wed Oct 20 07:28:43 CST 2021, time=2021-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062109, encodeId=cc221062109ad, content=关注医学, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210313/9df56058b3964a8cac82563f95f0389d/c1b478592e8e4463bef44d32712e98fd.jpg, createdBy=ea905324251, createdName=SR~young海东, createdTime=Tue Oct 19 22:51:30 CST 2021, time=2021-10-19, status=1, ipAttribution=)]
    2021-10-20 小蚂蚁uu

    心衰四连

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1073589, encodeId=9cef10e358979, content=有中文版的嘛, beContent=null, objectType=guider, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=31df6143751, createdName=ms6000001208327273, createdTime=Wed Nov 24 18:56:10 CST 2021, time=2021-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062246, encodeId=3167106224629, content=心衰四连, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07285599168, createdName=小蚂蚁uu, createdTime=Wed Oct 20 12:14:03 CST 2021, time=2021-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062161, encodeId=7cae106216112, content=！！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7d3a4700555, createdName=595690844, createdTime=Wed Oct 20 07:28:43 CST 2021, time=2021-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062109, encodeId=cc221062109ad, content=关注医学, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210313/9df56058b3964a8cac82563f95f0389d/c1b478592e8e4463bef44d32712e98fd.jpg, createdBy=ea905324251, createdName=SR~young海东, createdTime=Tue Oct 19 22:51:30 CST 2021, time=2021-10-19, status=1, ipAttribution=)]
    2021-10-20 595690844

    ！！

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1073589, encodeId=9cef10e358979, content=有中文版的嘛, beContent=null, objectType=guider, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=31df6143751, createdName=ms6000001208327273, createdTime=Wed Nov 24 18:56:10 CST 2021, time=2021-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062246, encodeId=3167106224629, content=心衰四连, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07285599168, createdName=小蚂蚁uu, createdTime=Wed Oct 20 12:14:03 CST 2021, time=2021-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062161, encodeId=7cae106216112, content=！！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7d3a4700555, createdName=595690844, createdTime=Wed Oct 20 07:28:43 CST 2021, time=2021-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062109, encodeId=cc221062109ad, content=关注医学, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210313/9df56058b3964a8cac82563f95f0389d/c1b478592e8e4463bef44d32712e98fd.jpg, createdBy=ea905324251, createdName=SR~young海东, createdTime=Tue Oct 19 22:51:30 CST 2021, time=2021-10-19, status=1, ipAttribution=)]
    2021-10-19 SR~young海东

    关注医学

    0